Southern Cross Acquisition I

Investors should note that while the IPO closed after the balance sheet date, the filing confirms the trust value is established at $10.00 per share and identifies the redemption deadline as July 22, 2027 (12 months post-IPO). The explicit 'going concern' warning highlights the binary risk: if no business combination is completed by the deadline, public shareholders face liquidation and potential loss of investment.

For investors tracking redemption calendars and trust dynamics, this filing definitively locks the trust balance at $115,000,000 ($10.00 per public share) and anchors the acquisition clock starting July 22, 2026. The documented waiver of sponsor redemption rights modifies the typical redemption math by removing sponsor selling pressure during any future tender offer or special meeting, potentially preserving higher per-share values for remaining public holders. Liquidity planning details $645,899 held outside the trust, with management stating founders may extend additional funds via working capital or extension loans convertible at $10.00 per unit if needed to fund operations or seek an extension. On deal strategy and screening, management states any initial target must carry an aggregate fair market value of at least 80% of the trust assets (excluding deferred underwriting commissions and released interest). Success probabilities embedded in the valuation methodology rest entirely on management's disclosed assumptions: a 40.0% estimated probability of successfully completing a business combination and a projected underlying stock price of $8.79 used for Black-Scholes models pricing public warrants and rights. Upon consummation, the registrant must remit $1,150,000 in deferred underwriting commissions, creating a fixed cash liability that reduces net enterprise value at close. These disclosures collectively define the strict timeline, sponsor skin-in-the-game alignment, capital maintenance obligations, and target acquisition thresholds governing the security's lifecycle.

Because the agreement governs only a procedural filing arrangement under the Securities Exchange Act of 1934, it bears no mechanical impact on shareholder redemption windows, trust preservation, capital deployment, or acquisition timelines. According to its explicit language, the signatories acknowledge only that their respective Schedule 13G statements (and any future Schedule 13D amendments) will be filed jointly on their mutual behalf. The document attributes no factual assertions regarding customer bases, operating revenue, market valuation, commercial strategy, technical infrastructure, partnership frameworks, litigation exposure, or executive personnel. Investors monitoring Southern Cross Acquisition I's SEARCHING phase should derive actionable intelligence solely from the referenced July 24, 2026 Schedule 13G filing and subsequent company announcements, as this attachment introduces no substantive operational or financial developments.

This filing establishes the initial trust value per share ($10.00), the trust account size ($115,000,000), the deadline for a business combination (July 22, 2027), and the sponsor's commitment to not redeem their shares. It confirms the SPAC is now live and searching for a target. Investors can now track future redemptions and extensions against this baseline.

The warrant exercise trigger is a two-part test - the later of 30 days after the combination and one year from effectiveness of the registration statement - so a fast combination does not make these warrants exercisable on the usual schedule. The combination period is only 12 months from closing. Warrants are redeemable at $0.01 once the shares close at or above $18.00 for 20 of 30 trading days commencing at least 30 days after the combination. Deferred underwriting of $1,000,000 ($1,150,000 with full over-allotment) sits in trust.

This is the IPO filing for a new SPAC, establishing the trust value ($10.00/share), the 12-month deadline, the sponsor's highly dilutive founder shares ($0.01-$0.0087 cost vs. $10.00 public), and the default rules for redemptions and liquidation. It signals the start of the redemption calendar. The China-ties disclaimer warns of jurisdiction and enforcement issues that could affect shareholder rights and deal completion. The sponsor's low cost basis creates a strong incentive to complete any deal before the deadline.

What changed: Southern Cross Acquisition I Corp. filed a 10-Q for the period ended June 30, 2026, reporting that it consummated its Initial Public Offering on July 22, 2026, issuing 11,500,000 Units at $10.00 per Unit for $115,000,000 in gross proceeds and placing $115,000,000 into a Trust Account. The filing discloses a working capital deficit of $281,439 as of June 30, 2026, and notes that management has determined substantial doubt exists regarding the Company's ability to continue as a going concern due to the mandatory liquidation date being less than one year from the issuance date. Why it matters: Investors should note that while the IPO closed after the balance sheet date, the filing confirms the trust value is established at $10.00 per share and identifies the redemption deadline as July 22, 2027 (12 months post-IPO). The explicit 'going concern' warning highlights the binary risk: if no business combination is completed by the deadline, public shareholders face liquidation and potential loss of investment.

What changed: Form 8-K Current Report (Items 8.01 and 9.01) accompanied by Exhibit 99.1, which is a press release. The Company announced that commencing on or about July 31, 2026, holders of the 11,500,000 units sold in its IPO may elect to separately trade the embedded ordinary shares, warrants, and rights. Per the press release authored by Chief Executive Officer Ally Tong Zhang, separated ordinary shares, warrants, and rights will trade on Nasdaq under the symbols NCO, NCOOW, and NCOOR, respectively, with each whole warrant exercisable at an exercise price of $11.50. Unsplitted units retain symbol NCOOU. Holders must instruct their brokers to contact Continental Stock Transfer & Trust Company to perform the separation. The filing notes that a Form S-1 registration statement was declared effective by the SEC on July 20, 2026, and D. Boral Capital LLC acted as the sole book-running manager for the underwritten offering. Why it matters: This filing executes a routine post-listing capitalization mechanic that increases trading liquidity without altering the SPAC’s redemption parameters, trust account conditions, or business combination timeline. The registrant stated it was formed to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination, and noted that its target search will not be limited to a particular industry or geographic region. No claims regarding customers, revenue, market size, strategy, technology, partnerships, litigation, or specific sponsor conduct details are provided.

What changed: A Joint Filing Agreement (Exhibit 7.1) attached to a Schedule 13D, serving as a procedural declaration that designated signatories consent to a single electronic submission on their behalf regarding beneficial ownership of Southern Cross Acquisition I Corp. ordinary shares. The exhibit delivers zero updates to the SPAC’s redemption calendar, trust valuation mechanics, extension voting schedule, target business combination progress, or sponsor governance conduct. It does not modify the stated search deadline, report any shareholder redemptions or tender elections, announce bridge capital, or detail how the sponsor intends to exercise its underwriting option or forward purchase rights. Why it matters: According to the Joint Filing Agreement executed by Director Dong Chen on behalf of Southern Cross Acquisition I Sponsor Corp., the parties merely authorized a consolidated filing dated July 29, 2026, covering ordinary shares with a par value of US$0.0001 each. As explicitly flagged in the filing header, the 'Structured holder table not present in this XML variant,' meaning no share volumes, ownership percentages, acquisition costs, or price-per-share metrics are actually reported. The document makes no assertions about customer pipelines, historical revenue, projected earnings, market size, technology infrastructure, partnership frameworks, regulatory litigation, or executive succession plans. Because the beneficial ownership data is omitted, this filing functions strictly as an administrative routing note; investors tracking redemption exposure, trust account sufficiency, or deal execution timelines must await an amended 13D that reconstructs the table and discloses concrete transaction parameters.

What changed: A Form 8-K current report filed by Southern Cross Acquisition I Corp. announcing the consummation of its initial public offering, accompanied by an audited balance sheet and detailed financial statement notes submitted as Exhibit 99.1. According to the registrant, on July 22, 2026, it consummated its IPO of 11,500,000 units at $10.00 per unit, including the full exercise of a 1,500,000-unit over-allotment option, generating $115,000,000 in gross proceeds. Substantially concurrently, the Sponsor purchased 239,300 private units for $2,393,000. The company states that $115,000,000 from these proceeds was deposited into a trust account with Continental Stock Transfer & Trust Company acting as trustee, establishing the per-share trust value at $10.00. The registrant specifies that the initial business combination must occur within 12 months of the July 22, 2026 closing, defining the mandatory redemption and liquidation deadline. The Sponsor waived redemption rights for its private units and agreed to a lock-up until the business combination concludes. Beyond redemption mechanics, management asserted that as of July 22, 2026, no potential target business had been selected and no substantive discussions had been initiated directly or indirectly. The company operates as a blank check entity incorporated in the Cayman Islands. Regarding capital structure, the Sponsor transferred 14,000 founder shares to the company's officers and independent director nominees for an aggregate consideration of $203.00. The registrant's management claims it will generate non-operating income solely from interest on trust proceeds and will not generate operating revenues until after completing a business combination. The independent registered public accounting firm (TAAD, LLP) included a going concern opinion in the attached financials, noting that the mandatory liquidation provision raises substantial doubt about the company's ability to continue as a going concern within one year of the statement's issuance. Why it matters: For investors tracking redemption calendars and trust dynamics, this filing definitively locks the trust balance at $115,000,000 ($10.00 per public share) and anchors the acquisition clock starting July 22, 2026. The documented waiver of sponsor redemption rights modifies the typical redemption math by removing sponsor selling pressure during any future tender offer or special meeting, potentially preserving higher per-share values for remaining public holders. Liquidity planning details $645,899 held outside the trust, with management stating founders may extend additional funds via working capital or extension loans convertible at $10.00 per unit if needed to fund operations or seek an extension. On deal strategy and screening, management states any initial target must carry an aggregate fair market value of at least 80% of the trust assets (excluding deferred underwriting commissions and released interest). Success probabilities embedded in the valuation methodology rest entirely on management's disclosed assumptions: a 40.0% estimated probability of successfully completing a business combination and a projected underlying stock price of $8.79 used for Black-Scholes models pricing public warrants and rights. Upon consummation, the registrant must remit $1,150,000 in deferred underwriting commissions, creating a fixed cash liability that reduces net enterprise value at close. These disclosures collectively define the strict timeline, sponsor skin-in-the-game alignment, capital maintenance obligations, and target acquisition thresholds governing the security's lifecycle.

What changed: Schedule 13G — beneficial ownership report filed on behalf of Sculptor Capital LP, Sculptor Capital II LP, Sculptor Capital Holding Corp, Sculptor Capital Holding II LLC, Sculptor Capital Management, Inc., and Sculptor Master Fund, Ltd. The filing discloses that the named Sculptor Capital entities are reporting beneficial ownership of NCO common stock. The provided text contains no share quantities, percentage breakpoints, purchase prices, acquisition dates, or contractual commitments. It does not alter the redemption calendar, modify trust distribution mechanics, propose an extension, or describe any target search activity or sponsor conduct. Why it matters: While a Schedule 13G does not mechanically impact the 2027-07-21 liquidation deadline or per-share trust accounting, it flags institutional capital deployment into a searching SPAC. Sculptor Capital’s accumulation warrants monitoring because such investors frequently engage on board composition, extension vote thresholds, and the structural conditions surrounding any future deSPAC transaction. Investors should track subsequent filings for breakpoint disclosures, joint actor statements, or explicit views on management’s timeline and redemption risk management. Until additional disclosures specify ownership levels or strategic intentions, the filing remains informational rather than operative.